Wallace joined Oxford Science Enterprises in March 2022. She focusses on uncovering new opportunities in Life Sciences, as well as supporting the creation of new businesses and the existing portfolio.
Wallace joined OSE from M-Ventures, the corporate venture capital arm of Merck KGaA, where she supported the life sciences investment team across scientific due diligence and portfolio management. Before this, Wallace worked at Accenture as a consultant, assisting the Business Strategy and Operation Strategy units, advising financial services clients.
Wallace holds a BSc in Genetics from the University of York and an MPhil in Bioscience Enterprise from the University of Cambridge.
